GTR 89970418
Request For Quotation Medical Devices
ICB — International Competitive Bid
Closed
Central Asia
Tender Information
GTR Reference
89970418
Tendering Authority
Subscribe to view
Tender No
13499036
Financer Name
Self-Funded
Work Title
Request For Quotation Medical Devices
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Central Asia
Political Region
Commonwealth of Independent States, CIS
Last Date of Bid Submission
23-12-2024
Closed
Work Detail
Powder For Preparation Of Solution For Infusions In A Set Of 1 G, Composition, One Vial Contains The Active Substance - Phosphocreatine Sodium Salt 1.0 G, Solvent - Water For Injections. Description Crystalline Powder Of White Or Yellowish Color., 5 G + Solvent - Water For Injections 50 Ml Lyophilized Powder For Preparation Of Solution For Intravenous Administration, 5 G, Complete With Solvent. Composition One Bottle Of The Drug Contains Active Substance - D-Fructose-1,6-Diphosphate Trisodium Salt 5G (Equivalent To 3.75G Of D-Fructose-1,6-Diphosphoric Acid). One Bottle Of Solvent Contains Water For Injections 50 Ml, Sterile Nitrogen. Fdp 5 G + Solvent - Water For Injections 50 Ml, Solution For Injection 40 Mg/Ml – 10 Ml 5 Ampoules. 1 Ml Contains 40.0 Mg Of The Active Substance - Deproteinized Hemoderivative Of Calf Blood (Calculated As Dry Matter). Auxiliary Substance: Water For Injections Contains About 26.8 Mg Of Sodium Chloride, Coated Tablets, 0.25 G No. 20 Tablet Contains The Active Substance: Amizone® (Enysamium Iodide) 0.25 G; Auxiliary Substances: Lactose Monohydrate, Microcrystalline Cellulose, Povidone, Croscarmellose Sodium, Calcium Stearate; Opadry Ii Clear Shell Composition (Opadry Ii Transparent 85F19250): Polyvinyl Alcohol, Talc, Polyethylene Glycol, Polysorbate 80. Description Round, Biconvex, Yellow Or Yellow-Green Coated Tablets. The Presence Of Insignificant Inclusions Is Allowed On The Surface Of Core Tablets. Pharmacotherapeutic Group Other Antiviral Drugs., No. 90 Tab One Tablet Contains Active Substances: Magnesium Lactate Dihydrate - 334 Mg (Equivalent To 34.00 Mg Magnesium), Pyridoxine Hydrochloride - 5 Mg Auxiliary Substances: Sodium Starch Glycolate (Type A), Magnesium Stearate, Microcrystalline Cellulose, 5 G/50 Ml No. 1 Por. One Vial Contains: Active Substance - Sodium Fructose-1.6-Diphosphate - 5.00 G, Corresponds To 3.75 G Of Fructose-1.6-Diphosphate Auxiliary Substance - Water For Injections. (Ezaphosphine), Lyophilized Powder For Preparation Of Solution For Intravenous Administration 600 Mg Complete With Solvent - Water For Injections 4 Ml Composition: One Vial With Powder Contains The Active Substance - Glutathione Reduced Sodium Salt 0.646 G Description: Crystalline Hygroscopic Powder From White To Yellowish Color. The Reconstituted Solution Is A Transparent Colorless Or Light Yellow Liquid, Capsules, No. 3 Fish Oil - 1000 Mg, Omega-3 Fatty Acids, Including - 342 Mg: Docosahexaenoic Acid (Dha) - 114 Mg, Eicosapentaenoic Acid (Epa) - 174 Mg; Vitamin D3 (Cholecalciferol) - 10 Mcg (400 Iu), 500 Mg No. 5 Amp. 5 Ml Lyophilized Powder For Preparation Of Solution For Intravenous And Intramuscular Administration 500 Mg Complete With Solvent 5 Ml One Bottle Contains Active Substance - Ademethionine 1,4-Butanedisulfonate 949 Mg (Equivalent To 500 Mg Of Ademethionine Cation) Auxiliary Substances: Water For Injections, Nitrogen. One Ampoule With Solvent Contains Active Substances: L-Lysine 428.0 Mg, Sodium Hydroxide 14.4 Mg Auxiliary Substance - Water For Injections. Lyophilized Powder Lyophilized Mass From White To Slightly Yellow Color, Free From Foreign Particles. Solvent Transparent Liquid From Colorless To Slightly Yellowish Color, Free From Foreign Particles, With A Characteristic Smell Of Amine. The Prepared Solution Of The Drug Is A Transparent Solution From Light Yellow To Yellow Color
Key Value
Tender Value
43,872,000 - KZT
Tender Documents
Global Tender Document
5565c3c9-45b3-418d-865e-64b9ba2fb3ac.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.